https://www.eupati.eu/"European Patients' Academy on Therapeutic Innovation" (EUPATI) has the objective to produce reliable and objective educational material to  patients on the research and development process of medicines in order to introduce a paradigm shift towards having patients much more actively engaged in medicines R&D.

EUPATI will provide scientifically reliable, objective, comprehensive information to patients and patient organization across Europe different languages (including Danish) on the research and development process of medicines from early start to market of new medicines.

The aim is to increase the capacity of patients to be effective advocates and advisors, e.g., in clinical trials, with regulatory authorities and in ethics committees and to make a visible difference, showing ways that can have a more meaningful involvement in areas like drug discovery, the safety of medicines and access to treatments.

EUPATI is a highly collaborative public private partnership project lead by patients consisting of 30 partners including patient advocacy groups, academic institutions, not-for-profit organisations and pharmaceutical companies.

Biopeople is consortia partner in EUPATI and plays a pivotal role in producing scientific reliable, objective and comprehensive educational material to patients across Europe.